drugset / Trial / NCT04983225

The Safety and Tolerability of Initial Periodontal Therapy Combined With Human Dental Pulp Stem Cell Injection in the Treatment of Chronic Periodontitis

NCT04983225 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

The principal objective of this trial is to investigate the safety and tolerability of human dental pulp stem cells injection in the treatment of chronic periodontitis. The secondary objective is to provide the basis for dosage regimen for further clinical trials and to evaluate the preliminary efficacy.

Timeline

Start
2021-07-31
Primary completion
2024-07-31
Completion
2024-08-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Human Dental Pulp Stem Cells Cell therapy 1e+06 cells Other
Subject Human Dental Pulp Stem Cells Cell therapy 5e+06 cells Other
Subject Human Dental Pulp Stem Cells Cell therapy 1e+07 cells Other
Subject Human Dental Pulp Stem Cells Cell therapy 2e+07 cells Other
Subject Human Dental Pulp Stem Cells Cell therapy 3e+07 cells Other
Subject Human Dental Pulp Stem Cells Cell therapy 4e+07 cells Other

Indications